Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
---|
01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
01/05/2011 | CN101939291A Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
01/05/2011 | CN101939055A 2-aminoquinolines |
01/05/2011 | CN101935301A Modulators of ATP-binding cassette transporters |
01/04/2011 | US7863294 Heterocycle derivatives as histone deacetylase (HDAC) inhibitors |
01/04/2011 | CA2521271C Quinoline-2-one-derivatives for the treatment of airways diseases |
01/04/2011 | CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
12/30/2010 | US20100331540 Method for producing compound having deuterated aromatic ring or heterocyclic ring |
12/30/2010 | US20100331334 Inhibitors of mek |
12/30/2010 | US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors |
12/30/2010 | US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
12/30/2010 | US20100327270 Novel materials for organic electroluminescent devices |
12/29/2010 | WO2010151791A1 Heterocyclic compounds and their uses |
12/29/2010 | WO2010151710A2 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof |
12/29/2010 | WO2010151011A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
12/29/2010 | WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
12/29/2010 | EP2265598A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof |
12/29/2010 | EP2265586A2 Preparation of montelukast and its salts |
12/29/2010 | EP1560827B1 Anti-infective agents |
12/29/2010 | EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
12/29/2010 | CN101928295A Antibiotics containing borinic acid complexes and methods of use |
12/29/2010 | CA2766033A1 Prodrugs of nh-acidic compounds |
12/29/2010 | CA2765823A1 Tricyclic heterocyclic compounds as mediators of p13k activity |
12/28/2010 | US7858794 such as 5-Chloro-thiophene-2-carboxylic acid (1-acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide, having follicle stimulating hormone modulatory activity, used to regulate fertility as contraceptives and for treatment of breast cancer, prostate cancer and endometriosis |
12/28/2010 | US7858793 Methyl 2-[(3S)-[3-[2E)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates |
12/28/2010 | US7858792 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma |
12/28/2010 | US7858652 e.g.1-(1H-imidazol-4-ylmethyl)-2-methyl-2,3-dihydro-1H-indole; trace amine associated receptors (g-protein coupled receptor), especially TAAR1; antidepressant, anxiolytic agent; psychosis, Parkinson's disease; reductively amination and coupling of indole and 5-methylketone-imidazol |
12/28/2010 | US7858642 Substituted hydroxyethylamine aspartyl protease inhibitors |
12/28/2010 | US7858640 Chemoattractant Receptor-homologous molecule expressed on T Helper cells type 2(CRTH2) antagonists, such as [8-chloro-3-(4-chlorobenzyl)-4-difluoromethoxy-2-ethylquinolin-5-yloxy]acetic acid, used as antiinflammatory agents or for the treatment of respiratory system, skin or gastrointestinal disorders |
12/23/2010 | WO2010148209A2 Preparation of montelukast |
12/23/2010 | WO2010146488A1 Bicyclic and tricyclic compounds as kat ii inhibitors |
12/23/2010 | WO2010088450A3 Arylamide derivatives useful in the treatment of diseases associated with serca activity |
12/23/2010 | US20100324266 Photocleavable Protecting Groups |
12/23/2010 | US20100324088 Fused Pyridone M1 Receptor Positive Allosteric Modulators |
12/23/2010 | US20100324086 Compounds and methods |
12/23/2010 | US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors |
12/23/2010 | US20100324025 Antibacterial Agents |
12/23/2010 | US20100324009 Substituted Sulfonamide Compounds |
12/23/2010 | US20100324000 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptors |
12/23/2010 | CA2763960A1 Bicyclic and tricyclic compounds as kat ii inhibitors |
12/22/2010 | EP2264037A1 Vasopressin v1a antagonists |
12/22/2010 | EP2263998A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
12/22/2010 | EP2262774A2 2-aminoquinolines |
12/22/2010 | EP2262773A1 2-aminoquinoline derivatives |
12/22/2010 | EP2262772A1 Quinoline derivatives as axl kinase inhibitors |
12/22/2010 | EP2262766A2 Amide compounds, compositions and uses thereof |
12/22/2010 | CN1993328B Quinoline derivative and insecticide containing same as active constituent |
12/22/2010 | CN1729158B Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
12/22/2010 | CN101925578A 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of ss-secretase (BACE) |
12/22/2010 | CN101921238A Preparation of substituted nitrogen-containing benzoheterocycle derivatives and pharmacological application thereof |
12/22/2010 | CN101921226A Substituted carboxylic ester compounds and application thereof |
12/21/2010 | US7855298 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia |
12/21/2010 | US7855297 Amide derivatives and medicinal use thereof |
12/21/2010 | US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
12/21/2010 | US7855207 such as 6-[(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-piperidin-1-ylpropyl]-3-ethyl-1H-quinolin-2-one, used for treating cancer and/or preventing cellular, tissue and/or organ damage resulting from cell damage or death due to, for example, necrosis or apoptosis |
12/21/2010 | US7855198 Benzamide derivative or salt thereof |
12/21/2010 | CA2477885C Pressurised metered dose inhalers containing solutions of beta-2 agonists |
12/21/2010 | CA2425567C Method of producing carboxylic acid salts |
12/16/2010 | WO2010144102A1 Pentafluorosulfanyl analogs of mefloquine |
12/16/2010 | WO2010144101A1 Next generation quinoloine methanols |
12/16/2010 | WO2010143170A2 Compounds useful for treating premature aging and in particular progeria |
12/16/2010 | WO2010143169A2 Compounds useful for treating aids |
12/16/2010 | WO2010143168A2 Compounds useful for treating cancer |
12/16/2010 | WO2010129467A8 Compounds and methods for inhibition of renin, and indications therefor |
12/16/2010 | WO2010116122A3 Herbicidal quinoline and 1,8 -naphthyridine compounds |
12/16/2010 | WO2010107329A3 Aripiprazole salts |
12/16/2010 | US20100317863 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof |
12/16/2010 | US20100317862 Use of compounds as inhibitors for helicobacter flavodoxin |
12/16/2010 | US20100317692 Quinolone M1 Receptor Positive Allosteric Modulators |
12/16/2010 | US20100317644 Substituted Sulfonamide Compounds |
12/16/2010 | US20100316605 Inhibitors of phosphatidylinositol 3-kinase |
12/16/2010 | CA2765053A1 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling |
12/16/2010 | CA2764027A1 Compounds useful for treating premature aging and in particular progeria |
12/16/2010 | CA2764026A1 Compounds useful for treating aids |
12/16/2010 | CA2764024A1 Compounds useful for treating cancer |
12/15/2010 | EP2261214A1 Compounds useful to treat premature aging and in particular progeria |
12/15/2010 | EP2261213A1 Heterocyclic compound |
12/15/2010 | EP2261212A2 Preparation of quinoline-substituted carbonate and carbamate derivatives |
12/15/2010 | EP2260025A2 Specific impurities of montelukast |
12/15/2010 | EP1613599B1 A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones |
12/15/2010 | CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis |
12/15/2010 | CN1863774B Compounds and compositions as protein kinase inhibitors |
12/15/2010 | CN101918366A Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
12/15/2010 | CN101918365A Inhibitors of human immunodeficiency virus replication |
12/15/2010 | CN101914059A Analytical reagent for detecting trace lead as well as preparation method and application thereof |
12/15/2010 | CN101068789B Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole |
12/15/2010 | CN101020658B Synthesis process of main cyclic quinoline compound |
12/14/2010 | CA2437944C Acylated indanyl amines and their use as pharmaceuticals |
12/14/2010 | CA2414787C Coumarin derivatives with comt inhibiting activity |
12/14/2010 | CA2412723C Benzothiazolyl ppar-gamma modulators |
12/09/2010 | WO2010141074A2 O-glcnac transferase inhibitors and uses thereof |
12/09/2010 | WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
12/09/2010 | WO2010139180A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
12/09/2010 | US20100311790 Amide compounds and plant disease controlling method using same |
12/09/2010 | US20100311735 Inhibitors of human immunodeficiency virus replication |
12/09/2010 | CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
12/08/2010 | EP2259068A2 Capture compounds and methods for analyzing the proteome |
12/08/2010 | EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis |
12/08/2010 | EP2258677A2 Histone deacetylase inhibitors and methods of use thereof |
12/08/2010 | EP2258676A1 Stable vinamidinium salt and nitrogen-containing heterocyclic ring synthesis using the same |